Celldex Therapeutics Stock Price Falls 1.9%
2026-09-22 21:37:02
According to CoinMeta, as reported by Reuters, the stock price of Celldex Therapeutics fell by 1.9% due to a poor market reaction following the release of late-stage trial data for its skin disease medication.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.